منابع مشابه
Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
In a recent article in this journal, the effectiveness of intravenous ketamine in treatment-resistant depression was highlighted (Katalinic et al., 2013). The following case reports describe the use of oral ketamine as augmentation treatment in patients presenting with chronic suicide ideation and at least two significant past suicide attempts. Mr B was a 44-year-old male with a history of bipo...
متن کاملModeling treatment-resistant depression.
Depression is a polygenic and highly complex psychiatric disorder that is currently a major burden on society. Depression is highly heterogeneous in presentation and frequently exhibits high comorbidity with other psychiatric and somatic disorders. Commonly used treatments, such as selective serotonin reuptake inhibitors (SSRIs), are not ideal since only a subset of patients achieve remission. ...
متن کاملTreatment-Resistant Depression
Approximately 32 to 35 million adults in the United States have an episode of major depression sometime during their lifetime, and many of them do not respond to initial treatment.1 The results of an analysis undertaken by Fava and Davidson2 suggest that between 29% and 46% of depressed patients fail to respond fully to antidepressant treatment of adequate dose and duration; about 15% of patien...
متن کاملTreatment-resistant depression.
Up to two thirds of patients with major unipolar depression will not respond to the first medication prescribed. Depression may be considered resistant to treatment when at least two trials with antidepressants from different pharmacologic classes (adequate in dose, duration, and compliance) fail to produce a significant clinical improvement. Evidence regarding the effectiveness of psychotherap...
متن کاملTreatment-Resistant Depression Issue Brief
Briefings such as this one are prepared in response to petitions to add new conditions to the list of qualifying conditions for the Minnesota medical cannabis program. The intention of these briefings is to present to the Commissioner of Health, to members of the Medical Cannabis Review Panel, and to interested members of the public scientific studies of cannabis products as therapy for the pet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Deutsches Aerzteblatt Online
سال: 2014
ISSN: 1866-0452
DOI: 10.3238/arztebl.2014.0766